---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-008311"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2022-12-09T23:59:59+00:00"
generated_at: "2026-06-21T06:46:20.704262+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences annual meeting adjourned on share-increase proposal; all directors elected

## Summary
- Elected all 7 director nominees: Borisenko, Callaway, Dastoor, Eisenberg, Kornberg, Logal, Vinogradov.
- Ratified Marcum LLP as independent auditor for FY2022 with 7.37M for, 58K abstained.
- Advisory vote on executive compensation approved: 4.23M for, 700K against, 66K abstain.
- Proposal 4 (increase authorized shares from 50M to 100M) adjourned to Dec 21; >80% of votes cast but not >50% of outstanding shares.

## SEC filing metadata
- accession: 0001683168-22-008311
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2022-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008311/0001683168-22-008311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008311/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-008311
- JSON: https://secwatch.observer/filing/0001683168-22-008311.json
- Plain text: https://secwatch.observer/filing/0001683168-22-008311.txt

## Key facts
- Shareholder Votes
  Xenetic Biosciences, Inc. shareholders approved Ratification of Marcum LLP as independent registered public accounting firm at the 2022-12-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: 2. The Company’s stockholders voted upon and approved the ratification of the selection of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022. The votes on this proposal were as follows: For Against Abstained Broker Non-Votes 7,370,441 434,234 58,570 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008311/0001683168-22-008311-index.htm
- Shareholder Votes
  Xenetic Biosciences, Inc. shareholders approved Advisory vote on named executive officer compensation at the 2022-12-07 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: 3. The Company’s stockholders voted upon and approved, on a non-binding, advisory basis, the Company’s named executive officer compensation. The votes on this proposal were as follows: For Against Abstained Broker Non-Votes 4,231,759 699,669 65,677 2,866,140
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008311/0001683168-22-008311-index.htm
- Shareholder Votes
  Xenetic Biosciences, Inc. shareholders approved Election of seven director nominees at the 2022-12-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-12-07
  source text: 1. The Company’s stockholders approved the election of the following seven nominees with each director receiving votes as follows: Name For Withheld Broker Non-Votes Dr. Grigory Borisenko 4,262,295 734,810 2,866,140 Dr. James Callaway 3,615,669 1,381,436 2,866,140 Mr. Firdaus Jal Dastoor 4,245,854 751,251 2,866,140 Mr. Jeffrey Eisenberg 4,271,238 725,867 2,866,140 Dr. Roger Kornberg 3,607,135 1,389,970 2,866,140 Mr. Adam Logal 4,253,923 743,182 2,866,140 Mr. Alexey Vinogradov 4,273,562 723,543 2,866,140
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008311/0001683168-22-008311-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.